Medical Radionuclides Platform

From PRISMAP to PRISMAP+, we strive to support medical research by providing innovative medical radionuclides for free and supporting your research. We achieve this by combining complementary production facilities with biomedical research facilities that are licenced to receive the radionuclides from our portfolio.

We offer access to the following goods, facilities and services:

  • Production and delivery of high-purity grade radionuclides for medical research
  • Access to a selection of medical research laboratories to perform the associated research
  • Preclinical research techniques in self-service or fully performed as a service
Apply for our servicesl
An introduction to our medical radionuclides portfolio
Elisa Malmer Martinsen
31 August 2026